Omalizumab's efficacy and safety against chronic spontaneous urticaria
© 2023 The Author(s)..
I have read the article titled, "Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China", by Wang et al with great interest. Nevertheless, there are a couple of questions raised in my mind. And clarification of some aspects of the study will help the reader benefit and have a better understanding of the study.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
The World Allergy Organization journal - 16(2023), 8 vom: 01. Aug., Seite 100808 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Özdemir, Öner [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic spontaneous urticaria |
|---|
| Anmerkungen: |
Date Revised 29.08.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.waojou.2023.100808 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361364814 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361364814 | ||
| 003 | DE-627 | ||
| 005 | 20231226085001.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.waojou.2023.100808 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1204.xml |
| 035 | |a (DE-627)NLM361364814 | ||
| 035 | |a (NLM)37638362 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Özdemir, Öner |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Omalizumab's efficacy and safety against chronic spontaneous urticaria |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.08.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Author(s). | ||
| 520 | |a I have read the article titled, "Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China", by Wang et al with great interest. Nevertheless, there are a couple of questions raised in my mind. And clarification of some aspects of the study will help the reader benefit and have a better understanding of the study | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chronic spontaneous urticaria | |
| 650 | 4 | |a Immunoglobulin E | |
| 650 | 4 | |a Omalizumab | |
| 773 | 0 | 8 | |i Enthalten in |t The World Allergy Organization journal |d 2008 |g 16(2023), 8 vom: 01. Aug., Seite 100808 |w (DE-627)NLM19437937X |x 1939-4551 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:8 |g day:01 |g month:08 |g pages:100808 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.waojou.2023.100808 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 8 |b 01 |c 08 |h 100808 | ||